Stellar Biotechnologies competitorsClear all

Stellar Biotechnologies's top competitors include Biogen and Ironwood Pharmaceuticals.
Stellar Biotechnologies
Stellar Biotechnologies
Stellar Biotechnologies is a biotechnology company.
Biogen
Biogen
Biogen is a biopharmaceutical company that discovers, develops, and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.
Founding Date
Founding Date
1999
Founding Date
1978
Founding Date
N/A
Type
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
Port Hueneme, US HQ
Locations
Cambridge, US HQ
Vicente López, AR
Macquarie Park, AU
Wien, AT
Machelen, BE
São Paulo, BR
Mississauga, CA
see more
Locations
Cambridge, US HQ
Boston, US
Employees
Employees
118% decrease
Employees
7,4005% decrease
Employees
31738% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
37.3 b
Valuation ($)
1.9 b
Twitter followers
Twitter followers
226
Twitter followers
35.2 k
Twitter followers
3.7 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
52
Number of tweets (last 30 days)
8
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
14.7
Average likes per tweet (last 30 days)
1.3
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
62.5%
Employee Rating
Employee Rating
N/A
Employee Rating
4
Employee Rating
4

Financial

Revenue (est.)
Revenue (est.)
$410.9k (FY, 2019)
Revenue (est.)
$14.4b (FY, 2019)
Revenue (est.)
$428.4m (FY, 2019)
Cost of goods
Cost of goods
$101.3k (FY, 2019)
Cost of goods
$2b (FY, 2019)
Cost of goods
$23.9m (FY, 2019)
Gross profit
Gross profit
$309.6k (FY, 2019)
Gross profit
$12.4b (FY, 2019)
Gross profit
$404.5m (FY, 2019)
Net income
Net income
($2.8m) (FY, 2019)
Net income
$5.9b (FY, 2019)
Net income
$21.5m (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 24.3m
Total funding raised
N/A
Total funding raised
$ 609m
For sources of this data, please see the company profile

View company profiles

Biogen
HQ
Cambridge, US
Employees
7,400↓ 5% decrease

Biogen is a biopharmaceutical company that discovers, develops, and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.

View company
Ironwood Pharmaceuticals
HQ
Cambridge, US
Employees
317↓ 38% decrease

Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.

View company